Citius Pharmaceuticals Stock Analysis

Citius Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.27. Some equities with similar Price to Book (P/B) outperform the market in the long run. Citius Pharmaceuticals recorded a loss per share of 5.76. The entity last dividend was issued on the 9th of June 2017. The firm had 1:25 split on the 26th of November 2024. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. Citius Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people. For more info on Citius Pharmaceuticals please contact Myron Holubiak at 908 967 6677 or go to https://citiuspharma.com.

Citius Pharmaceuticals Investment Alerts

Citius Pharmaceuticals Upcoming and Recent Events

Citius Largest EPS Surprises

View All Earnings Estimates

Citius Stock Institutional Investors

Note, although Citius Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Citius Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.31 M.

Citius Profitablity

Management Efficiency

Citius Pharmaceuticals has return on total asset (ROA) of (0.2532) % which means that it has lost $0.2532 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6053) %, meaning that it created substantial loss on money invested by shareholders. Citius Pharmaceuticals' management efficiency ratios could be used to measure how well Citius Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 07/23/2025, Return On Tangible Assets is likely to drop to -2.57. In addition to that, Return On Capital Employed is likely to grow to -0.57. At this time, Citius Pharmaceuticals' Total Assets are relatively stable compared to the past year. As of 07/23/2025, Non Current Assets Total is likely to grow to about 123.7 M, while Non Currrent Assets Other are likely to drop slightly above 41.6 K.

Technical Drivers

As of the 23rd of July, Citius Pharmaceuticals shows the Downside Deviation of 7.63, risk adjusted performance of 0.1001, and Mean Deviation of 7.74. Citius Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Citius Pharmaceuticals variance and potential upside to decide if Citius Pharmaceuticals is priced correctly, providing market reflects its regular price of 1.67 per share. Please also double-check Citius Pharmaceuticals total risk alpha, which is currently at (1.00) to validate the company can sustain itself at a future point.

Citius Pharmaceuticals Price Movement Analysis

Citius Pharmaceuticals Insider Trading Activities

Citius Pharmaceuticals Outstanding Bonds

Citius Pharmaceuticals Predictive Daily Indicators

Citius Pharmaceuticals Forecast Models

Citius Pharmaceuticals' time-series forecasting models are one of many Citius Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Citius Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Citius Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Citius shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Citius Pharmaceuticals. By using and applying Citius Stock analysis, traders can create a robust methodology for identifying Citius entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Citius analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Citius analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Citius Pharmaceuticals stock analysis indicators help investors evaluate how Citius Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Citius Pharmaceuticals shares will generate the highest return on investment. By understating and applying Citius Pharmaceuticals stock analysis, traders can identify Citius Pharmaceuticals position entry and exit signals to maximize returns.

When running Citius Pharmaceuticals' price analysis, check to measure Citius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Citius Pharmaceuticals is operating at the current time. Most of Citius Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Citius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Citius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Citius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.